期刊文献+

FSTL1在骨髓间充质干细胞保护大鼠心肌缺血再灌注损伤中的作用 被引量:3

Follistatin-like 1-engineered mesenchymal stem cells prevent myocardial ischemic reperfusion injury
原文传递
导出
摘要 目的 研究卵泡抑素样蛋白1(FSTL1)在骨髓间充质干细胞(BM-MSCs)保护心肌缺血/再灌注损伤中的作用.方法 全骨髓贴壁法培养BM-MSCs.构建大鼠心肌缺血再灌注损伤模型,60只Wistar大鼠随机分为4组(每组15只):心肌缺血再灌注损伤模型假手术组,心肌缺血再灌注模型(IRI)组,心肌缺血再灌注模型注射正常BM-MSCs细胞(IRI+ MSC)组,心肌缺血再灌注模型注射敲低FSTL1的BM-MSCs细胞(IRI+ MSC FSTL1 siRNA)组.分析大鼠生存时间,Western印迹法检测大鼠心肌组织FSTL1表达情况.术后7d计算大鼠心肌梗死面积,HE染色检测心肌病理变化,脱氧核糖核苷酸末端转移酶介导的缺口末端标记法(TUNEL)检测细胞凋亡,同时酶联免疫吸附法(ELISA)检测各组血清乳酸脱氢酶(LDH)、磷酸肌酸激酶(CK)、心肌组织丙二醛(MDA)和超氧化物歧化酶(SOD)水平.结果 相较IRI组,IRI+ MSC组大鼠生存率及存活时间均显著延长,同时外周血及心脏组织中FSTL1蛋白表达明显增高;相较假手术组,IRI组大鼠心肌细胞凋亡率[(29.8±4.5)%比(1.4±0.1)%,P<0.05]、病理损伤及心肌梗死面积(24.48±4.27比0,P<0.05)均明显增加,而IRI+ MSC组大鼠心肌细胞凋亡[(4.2±0.3)%比(29.8±4.5)%,P<0.05]、病理损伤情况有明显改善,心肌梗死面积也较IRI组大鼠减少(15.12±3.82比24.48±4.27,P<0.01),LDH、MDA及CK表达降低,SOD表达增加(P<0.05);但是当移植敲低了FSTL1的BM-MSCs后心肌保护作用明显降低(P<0.05).结论 间充质干细胞可能通过分泌FSTL1从而减少大鼠心肌梗死面积,进而起到心肌保护的作用. Objective To investigate the role of follistatin-like protein 1 (FSTL1) on bone marrow mesenchymal stem cells (BM-MSCs)-mediated cardioprotection during myocardial ischemia/reperfusion injury.Methods Rat bone marrow mesenchymal stem cells were isolated by whole bone marrow adherence method in vitro.A total of 60 Wistar rats were randomly divided into 4 groups:control group,ischemic / reperfusion injury (IRI) group,ischemia/reperfusion injury group treated with natural BM-MSCs (IRI + MSC group),ischemia/reperfusion injury group treated with BM-MSCs which did not contain FSTL1 (IRI + MSC FSTL1 siRNA group).Survival analysis was used to analyze survival time of rats,besides,expression of FSTL1 was detected by Western blotting.Myocardial pathological changes were detected by Hematoxylin and Eosin (HE) staining.Terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) and enzyme-linked immunosorbent assay (ELISA) were used to determine the associated biomarkers and apoptosis 7 days after operation.Results Compared with IRI group,rats in IRI + MSC group had a higher survival rate and lived longer.Meanwhile,IRI + MSC group had higher FSTL1 expression in blood and myocardial tissues than IRI group.Control group showed significantly lower apoptosis rate of myocardial cells [(1.4 ± 0.1) % vs (29.8 ± 4.5) %,P 〈 0.05],less histological changes and infarction areas (0 vs 24.48 ± 4.27,P 〈 0.05) than IRI group.Compared with IRI group,IRI + MSC group had an improvement of apoptosis rate [(4.2 ± 0.3) % vs (29.8 ± 4.5) %,P 〈 0.05],less histological injury and infarction areas (15.12 ± 3.82 vs 24.48 ± 4.27,P 〈 0.01).IRI + MSC group had lower expression of LDH,MDA,CK and higher expression of SOD than IRI group (P 〈 0.05).However,IRI + MSC FSTL1 siRNA group showed weaker protection of myocardial cells than IRI + MSC group after knockdown of FSTL1 (P 〈 0.05).Conclusion FSTL1,which was secreted by BM-MSCs,plays a protective role in myocardial IRI.
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第25期2017-2022,共6页 National Medical Journal of China
基金 基金项目:浙江省自然科学基金(LY13H150009,LY16H160043) 浙江省医药卫生科技计划一般项目(2016KYA022,2015KYB033)
关键词 卵泡抑素相关蛋白质类 间质干细胞 心肌再灌注损伤 Follistatin-related proteins Mesenchymal stem cell Myocardial reperfusion injury
  • 相关文献

参考文献20

  • 1Wu H, Ye M, Yang J, et al. Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K/Akt signaling pathway [J]. Cell Physiol Biochem, 2015, 35 (6) : 2320-2332. DOI: 10. 1159/000374035.
  • 2Yu P, Zhang J, Yu SC, et al. Protective Effect of sevoflurane postconditioning against cardiac ischemiafreperfusion injury via ameliorating mitochondrial impairment, oxidative stress and rescuing autophagic clearance [ J]. PLoS One, 2015, 10 ( 8 ) : e0134666. DOI: 10. 1371/joumal. pone. 0134666.
  • 3Zhang J, Wang C, Yu S, et al. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling[ J]. Sci Rep, 2014, 4 : 7317. DOI: 10. 1038/srep07317.
  • 4Bussolati B, Hauser PV, Carvalhosa R, et al. Contribution of stem cells to kidney repair[ J]. Curr Stem Cell Res Ther, 2009,4 (1) : 2-8.
  • 5A1-Khaldi A, A1-Sabti H, Galipeau J, et al. Therapeutic angiogenesis using autologous bone marrow stromal ceils : improved blood flow in a chronic limb ischemia model [ J ]. Ann Thorac Surg, 2003, 75 ( 1 ) :204-209.
  • 6Deuse T, Peter C, Fedak PW, et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction [J]. Circulation, 2009,120 ( 11 Suppl ) : s247-s254. DOI: 10. 1161/CIRCULATIONAHA. 108. 843680.
  • 7Kim SH, Moon HH, Kim HA, et al. Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury [ J]. Mol Ther, 2011 , 19 (4) : 741-750. DOI: 10. 1038/mt. 2010. 301.
  • 8Patel K, Connolly DJ, Amthor H, et al. Cloning and early dorsal axial expression of Flik, a chick follistatin-related gene : evidence for involvement in dorsalizafion/neural induction [J]. Dev Biol, 1996, 178(2) : 327-342.
  • 9Ni S, Miao K, Zhou X, et al. The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-KB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation[J]. Arthritis Res Ther, 2015, 17: 91. DOI: 10. 1186/sl 3075-015-0605-6.
  • 10Xu J, Qi X, Gong J, et al. Fstll antagonizes BMP signaling and regulates ureter development [ J ] . PLoS One, 2012, 7 (4) : e32554. DOI: 10. 1371/iournal. none. 0032554.

二级参考文献29

  • 1陈延英,孟凌新,贾有海,赵广翊,崔健君.艾司洛尔对心肺复苏大鼠心肌线粒体ATP酶活性的影响[J].解放军医学杂志,2007,32(2):115-117. 被引量:2
  • 2Aggarwal S, Pittenger MF. Human mesenchymal stem ceils modulate allogeneic immune cell responses. Blood, 2005, 105 : 1815-1822.
  • 3刘铜林,杨敬.外周血淋巴细胞的选择性分离//沈关心,周汝麟.现代免疫学实验技术.武汉:湖北科学技术出版社,1998:290-295.
  • 4Frassoni FLM, Bacigalupo A, Gluckman E. Expanded mesenchymal stem cells (MSC), eoinfused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft remus host disease: a matched pair analysis. Bone Marrow Transplant, 2002, 29:75.
  • 5Rasmusson I, Ringd'en O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003, 76 : 1208-1213.
  • 6Zhang W, Ge W, Li CH, et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev, 2004, 13 : 263- 271.
  • 7Honda K, Nakano H, Yoshida H, et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patchorganogenesis. J Exp Med, 2001, 193:621- 630.
  • 8Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107:367-372.
  • 9Manro K, Sarah G, Julian D, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and antigen-spocific T cells to their cognate peptide. Blood, 2003, 101:3722.
  • 10Di Nieola M, Carlo Stella C, Magni M, et al. Human bone marrow stromal cells suppress T lymphocyte proliferation induced by celhdar or nonspecific mitogenic stimuli. Blood, 2002, 99: 3838-3843.

共引文献22

同被引文献23

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部